Recursion Pharmaceuticals

OverviewSuggest Edit

Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology. The company uses high-throughput genetic manipulation to model diseases in multiple human cell types. 
TypePublic
Founded2013
HQSalt Lake City, UT, US
Websiterecursionpharma.com
Employee Ratings4.7
Overall CultureA+

Latest Updates

Employees (est.) (Feb 2021)216
Share Price (May 2021)$33(-1%)
Cybersecurity ratingCMore

Key People/Management at Recursion Pharmaceuticals

Chris Gibson

Chris Gibson

Co-Founder and CEO
Sharath Hegde

Sharath Hegde

Chief Scientific Officer
Heather Kirkby

Heather Kirkby

Chief People Officer
Tina Larson

Tina Larson

President and COO
Michael Secora

Michael Secora

Chief Financial Officer
Mason Victors

Mason Victors

Chief Product Officer
Show more

Recursion Pharmaceuticals Office Locations

Recursion Pharmaceuticals has an office in Salt Lake City
Salt Lake City, UT, US (HQ)
41 S Rio Grande St
Show all (1)

Recursion Pharmaceuticals Financials and Metrics

Recursion Pharmaceuticals Revenue

Market capitalization (3-May-2021)

5.5b

Closing stock price (3-May-2021)

33.0
Recursion Pharmaceuticals's current market capitalization is $5.5 b.
Show all financial metrics

Recursion Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Recursion Pharmaceuticals Online and Social Media Presence

Embed Graph

Recursion Pharmaceuticals Company Culture

  • Overall Culture

    A+

    90/100

  • CEO Rating

    A+

    93/100

  • Compensation

    A+

    89/100

Learn more on Comparably

Recursion Pharmaceuticals News and Updates

Recursion Pharmaceuticals amasses $121 mln Series C

Salt Lake City-based Recursion Pharmaceuticals, a next-gen biopharma company, has secured $121 million in Series C financing. Baillie Gifford’s flagship investment trust Scottish Mortgage Investment Trust PLC led the round.

Biotech company Recursion Pharmaceuticals fetches $60 mln Series B

Salt Lake City-based Recursion Pharmaceuticals, a biotechnology company, has secured $60 million in Series B financing. Data Collective led the round.

Recursion Pharmaceuticals Blogs

Building a Start-up Ecosystem for Utah Biotech Entrepreneurs

The post Building a Start-up Ecosystem for Utah Biotech Entrepreneurs appeared first on Recursion Pharmaceuticals.

Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2

The post Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2 appeared first on Recursion Pharmaceuticals.

Recursion Pharmaceuticals Frequently Asked Questions

  • When was Recursion Pharmaceuticals founded?

    Recursion Pharmaceuticals was founded in 2013.

  • Who are Recursion Pharmaceuticals key executives?

    Recursion Pharmaceuticals's key executives are Chris Gibson, Sharath Hegde and Heather Kirkby.

  • How many employees does Recursion Pharmaceuticals have?

    Recursion Pharmaceuticals has 216 employees.

  • Who are Recursion Pharmaceuticals competitors?

    Competitors of Recursion Pharmaceuticals include G3T, Aegicare and OneThree Biotech.

  • Where is Recursion Pharmaceuticals headquarters?

    Recursion Pharmaceuticals headquarters is located at 41 S Rio Grande St, Salt Lake City.

  • Where are Recursion Pharmaceuticals offices?

    Recursion Pharmaceuticals has an office in Salt Lake City.

  • How many offices does Recursion Pharmaceuticals have?

    Recursion Pharmaceuticals has 1 office.